PATH | VRL
Menu

Estimating the Full Public Health Value of Vaccination

This conference report, published in Vaccine, builds upon a discussion in the public health community on how to assess and incorporate, in addition to safety and measures of protective efficacy, the full public health value (FPHV) of preventive vaccines into the evidence-based decision-making process of vaccine licensure and recommendations for public health use. Following an initial conference at the Fondation Mérieux in mid-2015, this article reports on a second conference held in December 2016. The expert panel reviewed the concept of FPHV as well as case studies about several vaccines being adopted and in the pipeline. They concluded that while progress has been made, additional efforts will be necessary to have a more fully formulated assessment of the FPHV of vaccines.

Author: Gessner BD, Kaslow D, Louis J, et al.

Published: 2017

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Gessner BD, Kaslow D, Louis J, et al. Estimating the Full Public Health Value of Vaccination. Vaccine. 2017;35(46):6255-6263.

Resource types: Peer-reviewed journal

Diseases/vaccines: Malaria, Rotavirus, Influenza, Respiratory syncytial virus (RSV), Group B Streptococcus (GBS)

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Global